Account Info
Log Out
English
Back
Log in to access Online Inquiry
Back to the Top

Novavax trails vaccine developers after setback for COVID-19 shot in India

$Novavax (NVAX.US)$ has lagged rival developers of COVID-19 vaccines after the newly detected coronavirus variant Omicron sparked a rally across the subsector on Friday amid a market selloff.
The company shares underwent a brief trading halt previously after news emerged that regulators in India had sought additional data from the company’s partner there before a potential authorization for its vaccine named Covovax.
The Drugs Controller General of India (DCGI) had noted that Covovax also called NVX-CoV2373 had not yet been cleared in its country of origin, Business Standard, reports.
While FDA has yet to authorize the protein subunit vaccine against COVID-19, Novavax has already won the Emergency Use Authorization (EUA) for the vaccine in both Indonesia and the Philippines.
Novavax trails vaccine developers after setback for COVID-19 shot in India
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
1
1
19
+0
11
Translate
Report
26K Views
Comment
Sign in to post a comment

View more comments...

423Followers
9Following
483Visitors
Follow